TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2015

Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors.

Jennifer A Kanakry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.